This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Association of clonal haematopoiesis with heartfailure incidence and outcomes: A systematic review and meta-analysis. Clonal haematopoiesis and heartfailure: a meta-analysis. CH, clonal haematopoiesis; CI, confidence interval; HF, heartfailure.
In the ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial, researchers examined the risk of ischemic events in patients with stable coronaryarterydisease. years, with 57.1% occurring within 30 days after CABG. years, with 21.1% occurring within 30 days after PCI.
Objective To explore trends in prognosis and use of glucose-lowering drugs (GLD) in patients with diabetes and coronaryarterydisease (CAD). Information on GLD (dispended 6 months before or after coronary angiography) was collected from the Swedish Prescribed Drug Registry. vs. 10.5%) and chronic kidney disease (3.7%
BackgroundAcute psychological stress may induce physiological changes predisposing individuals to adverse health outcomes through hemodynamic and vascular effects. The outcome was a composite of cardiovascular death, nonfatal myocardial infarction, and heartfailure hospitalizations during followup.
Circulation: Cardiovascular Quality and Outcomes, Volume 17, Issue 12 , Page e011040, December 1, 2024. BACKGROUND:Posttraumatic stress disorder (PTSD) is associated with maladaptive dysregulation of stress response systems, which could lead to an increased risk of heartfailure. 95% CI, 2.67.3). 95% CI, 2.16.3]).
ObjectivesRevascularization in patients with severely reduced left ventricular function and coronaryarterydisease (CAD) is associated with a high perioperative risk.
About Chronic Myocardial Ischemia with Refractory Angina Chronic myocardial ischemia occurs in the setting of coronaryarterydisease when there is reduced blood flow to the heart. million patients in the United States. CAUTION - Limited by United States law to investigational use.
Its effects on the heart are particularly alarming, as smoking significantly increases the risk of cardiovascular diseases (CVDs) and complicates medical procedures such as minimally invasive or bloodless heart surgeries. Reduced Long-Term Success Rates For smokers, the long-term success of heart surgeries is often diminished.
Journal of the American Heart Association, Ahead of Print. BackgroundLiterature suggests a bidirectional association between advanced hepatic fibrosis (AHF) and coronaryarterydisease (CAD). They were more likely to experience the following adverse outcomes: all‐cause death (adjusted hazard ratio [HR], 1.57 ([95% CI, 1.29–1.92];P<0.001)
Background This study investigated the relationship between coronaryarterydisease–reporting and data system (CAD-RADS) for coronary computed tomography angiogram (CCTA) and major adverse cardiovascular and cerebral event (MACE) in a symptomatic Southeast Asian, Thai population over a 5-year period.
Cardiac amyloidosis is a heterogeneous disease that results from the accumulation of abnormal proteins within the heart, impairing its ability to pump blood. Over time, the build-up of these proteins causes the heart muscle to stiffen, eventually leading to heartfailure, which can have dire outcomes if not found early.
Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. BACKGROUND:Ischemic cardiomyopathy is the leading cause of heartfailure (HF). Most patients do not undergo coronary assessment after HF diagnosis. Women, older individuals, and people without stable housing were less likely to complete coronary assessment.
Decline in exercise ability is a hallmark of progression to overt heartfailure. These results also speak to the importance of continuing to focus on earlier recognition of heartfailure risk in patients with diabetes and on initiating treatment before the condition has progressed to overt heartfailure.”
Background:Randomized trials in obstructive coronaryarterydisease (CAD) have largely shown no prognostic benefit from coronary revascularization. We identified the presence and cause of cardiomyopathy using CMR and coronary angiography data, blinded to clinical outcomes. Circulation, Ahead of Print.
In this study, two independent cohorts were used to investigate for cardiovascular magnetic resonance (CMR) and genetic features of dilated cardiomyopathy (DCM) in individuals with coronaryarterydisease (CAD). NI-LGE was not independently associated with adverse clinical outcomes. vs. 6.7%, odds ratio 1.5,
Featured topics will include in-depth sessions covering non-statin lipid lowering therapies, heartfailure with preserved ejection fraction, viability, imaging modalities for the assessment of coronaryarterydisease, and antiplatelet therapy after coronary stenting. Too Many Choices?
Abstract Diagnosing heartfailure is often difficult due to the non-specific nature of symptoms, which can be caused by a range of medical conditions. Natriuretic peptides (NPs) have been recognized as important biomarkers for diagnosing heartfailure. Use of this acronym would enable the early diagnosis of heartfailure.
fold higher risk for major adverse cardiac events (MACE) Caristo's AI-Risk model, CaRi-Heart Risk Score, outperformed other scores in routine clinical use for prediction of cardiac mortality, and when presented to clinicians, resulted in changes of management decision in 45% of the patients. fold higher risk for cardiac mortality and 5.5-fold
It is now well known that even if a coronaryartery is opened well after a myocardial infarction, with good flow in the epicardial coronaryarteries, there could be impaired myocardial perfusion. In the initial era of primary PCI, angiographic myocardial blush was taken as a surrogate of effective myocardial reperfusion.
An increasing number of studies have shown the impact of social determinants of health (SDoHs) on different cardiovascular outcomes. In the setting of arrhythmias, specific SDoHs can increase the incidence of atrial fibrillation and adversely affect major outcomes in these patients.
ABSTRACT Aims The aim of this analysis was to provide data on the overall comorbidity burden, both cardiovascular (CV) and non-CV, in a large real-world heartfailure (HF) population across the ejection fraction (EF). All comorbidities, except for coronaryarterydisease (CAD), were more frequent in HF with preserved EF (HFpEF).
The primary outcome was a composite of inhospital adverse events. Associations between multimorbidity patterns and outcomes were evaluated using multivariableadjusted logistic regression models. years]) admitted to the China Chest Pain Center Database between 2016 and 2021. Among 9570 patients, 50% (n=4789) had multimorbidity.
We aimed to investigate the impact of albumin levels and their changes on clinical outcomes among patients who were admitted to intensive care units due to cardiac causes.Methods:This is a retrospective, single-center, cohort study. Consecutive patients admitted to coronary care unit (CCU) were enrolled between January 2011 and December 2020.
Cardiovascular medications frequently lead this category, often contributing to adverse clinical outcomes, including emergency department visits and hospitalizations. Drugs That May Cause or Exacerbate HeartFailure: A Scientific Statement from the American Heart Association. BMC Med2015;13(74). Circulation. Circulation.
The new FDA-cleared AI-enabled applications include the industry’s first automated tool for segmental wall motion scoring of the heart to quickly and objectively identify disorders including coronaryarterydisease and cardio-oncology issues in seconds.
Migraine with aura(MwA) is associated with an increased risk of stroke and adverse vascular outcomes compared to those with migraine without aura (MwoA). Patients with any adverse vascular outcomes before the index ECG were excluded. The prevalences of all vascular outcomes are summarized in Table 1. p < 001).
Diabetes is a risk factor for acute ischemic stroke and also a poor predictor of outcome for many interventional surgeries. We performed this retrospective cohort analysis to assess the impact of poorly controlled diabetes, defined as HbA1C of 9.0% or greater. vs. 20.5%; p = 0.048) and stenting (28.4%
Aims Patients with heartfailure usually have several other medical conditions that might alter the effects of interventions. A prior history of the following comorbidities was considered: episodic or persistent atrial fibrillation ( n = 920), coronaryarterydisease ( n = 3732), diabetes ( n = 2171), and hypertension ( n = 3353).
Investigators assessed if empagliflozin could lower the risk of hospitalization for heartfailure (HF) or death from cardiovascular disease (CVD). The percent change from baseline in fasting triglycerides (TG) at six months served as the primary outcome measure.
We compared demographics, hospital traits, comorbidities, and outcomes. In-hospital mortality, our primary outcome, was analyzed through multivariate logistic regression using STATA 18.Results:Incorporating Regarding comorbidities, congestive heartfailure (OR 1.73, p <0.01, CI 1.32
Introduction:Mechanical Thrombectomy improves outcomes in patients with acute ischemic stroke due to large vessel occlusion. Records were reviewed for the study outcome which was recurrent ischemic stroke during the in-hospital period, defined as new or worsening neurological symptoms due to new infarct or extension of the infarct.
AF-CHF trial in those with AF and congestive heartfailure also failed to show any advantage for the rhythm control strategy [3]. Overall, it appears that rhythm control strategy in AF may be better in those with heartfailure and in those with associated cardiovascular conditions and early AF.
Regardless of what is driving the effect, it is clear that experiencing high levels of stress is associated with worse outcomes. 24% increased risk of coronaryarterydisease. That event might have been a heart rhythm issue or even a cardiac arrest. This is more commonly known as ‘Broken Heart Syndrome.
Studies have reported racial disparities in young stroke patients and less desired outcomes of minorities. Socioeconomic status, risk factors, stroke etiology, acute interventions and short-term outcomes were accessed. Introduction:A rising prevalence of stroke in young patients was noticed in recent years. were male, and 60.4%
The Role of Cardiologists Cardiologists are at the forefront of the battle against heartdiseases. Their expertise covers a wide range of cardiovascular conditions, including coronaryarterydisease, heartfailure, arrhythmias, and congenital heart defects.
There are significant data that show that if you have obesity, you have a high risk of developing coronaryheartdisease, heartfailure, type 2 diabetes (T2D) or risk factors such as hypertension and dyslipidemia. [1] Is the obesity paradox a real phenomenon?
This 3-day event will bring together a world-class, international faculty to explore the latest developments and best practices in coronaryarterydisease, congenital heartdisease, thoracic aortic disease, atrial fibrillation, and the surgical management of heartfailure.
Outcomes of interest included symptomatic intracerebral hemorrhage (ICH), asymptomatic ICH, hemorrhagic transformation, mass effect and death. Per local practice patterns, patients who underwent angioplasty or stenting were immediately started on dual antiplatelets with or without a glycoprotein IIb/IIIa inhibitor bridge.
These technologies are not just reshaping but also empowering how cardiology practices manage operations, deliver care, and enhance patient outcomes. These technologies are reshaping how cardiology practices manage operations, deliver care, and enhance patient outcomes.
He denied any known medical history, specifically: coronaryarterydisease, hypertension, dyslipidemia, diabetes, heartfailure, myocardial infarction, or any prior PCI/stent. Vital signs were noted to be unremarkable with respect to any hypo-hypertensive crisis, hypoxia, etc. No appreciable skin pallor.
I do this for three reasons: There is a relationship between short sleep and worse cardiovascular outcomes. To assess if they have a sleep condition called obstructive sleep apnea, which is also tightly linked to cardiovascular disease and can be treated. When a patient joins my practice, I always ask about sleep.
The highly impactful International Study of Comparative Health Effectiveness With Medical and Invasive Approaches ( ISCHEMIA ) trial investigated the effectiveness of invasive (INV) versus conservative (CON) strategies for managing stable coronaryarterydisease. Original article: Gaudino M et al. EuroIntervention.
However, the role of body composition, including body fat percentage and lean body mass (LBM), in cardiovascular outcomes has not been well studied in patients with coronaryarterydisease (CAD). Future research studying the implications of changes in body composition on outcomes in men and women with CAD is warranted.
Objective Antithrombotic therapy is essential for patients with atrial fibrillation (AF) and stable coronaryarterydisease (CAD) because of the high risk of thrombosis, whereas a combination of antiplatelets and anticoagulants is associated with a high risk of bleeding.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content